/4thromboembolic and hemodynamic mecha-.LXknisms may have a role in the development of cerebral ischemia. Although antiplatelet therapy may be of value in preventing thromboembolic stroke, it is unlikely to prevent hemodynamic ischemia. Measurement of cerebral blood flow (CBF) by single-photon emission computed tomography (SPECT) with vasodilatory stimuli has the possibility of detecting patients with ICA occlusion who are hemodynamically compromised.' However, it is unclear how to medically manage such patients with a high risk of hemodynamic ischemia. 2 Hemodilution increases CBF in both normal and ischemic brain3,4 and thus has the potential to improve the hemodynamically compromised state of patients with ICA occlusion. However, the effect of hemodilution on cerebral oxygen transport and metabolism re-mains unclear. In the normal brain, the increase of CBF by hemodilution probably is a physiological regulatory mechanism that maintains oxygen transport to the tissues at a constant level, along with vasodilatation in response to a reduced oxygen content.35 Therefore, hemodilution may decrease oxygen transport if the perfusion pressure is low enough, and this would cause maximal vasodilatation. 6 In the ischemic brain, however, a direct hemorrheologic effect is also suggested to augment CBF7 and increase oxygen transport. Therefore, hemodilution may improve oxygen transport in patients with ICA occlusion and low perfusion.
The purpose of this study was to evaluate the effects of isovolemic hemodilution on cerebral hemodynamics and oxygen metabolism in patients with chronic symptomatic ICA occlusion by using positron emission tomography (PET) and to examine the effect of hemodilution on patients in a hemodynamically compromised state.
Subjects and Methods
We studied four men and one woman aged 48 to 68 years (mean-+-SD, 60.4+ 7.6 years) who had angiographically proven unilateral ICA occlusion. They consisted of one patient with transient ischemic attacks and four with minor completed strokes. Only subcortical abnormalities were detected in the middle cerebral artery (2. 96 GBq) was used to measure cerebral blood volume (CBV). We calculated CBF, CMRo2, and OEF based on the steadystate method.9 CMRo2 and OEF were corrected by the CBV.10 Functional images were reconstructed as 64 x 64 pixels, with each pixel representing 2.5 x 2.5 mm. The subjects underwent phlebotomy of 400 mL and infusion of 400 mL of 6% hydroxyethyl starch over 30 to 40 minutes for isovolemic hemodilution. PET studies were repeated immediately after hemodilution. In all patients, PET was performed at least 1 month after the latest ischemic event.
We analyzed three tomographic planes, which were 4.0, 6.6, and 8.2 cm above and parallel to the orbitomeatal line and corresponded to the basal ganglia and thalamus, the body of the lateral ventricles, and the centrum semiovale, respectively. For determination of the cerebral regions of interest (ROIs), each of the three images was used to place a total of 18 to 20 circular ROIs, each 11 pixels (0.6875 cm2), over the cortex. According to the atlas of Kretschmann and Weinrich,11 the ROIs in all three images were in the distribution of the anterior cerebral artery (ACA), the MCA, and the posterior cerebral artery (PCA), as well as in the watershed areas between the ACA and MCA (anterior watershed [AWS] ) and the MCA and PCA (posterior watershed [PWS] ). The hemispheric value was calculated as the average of the MCA, AWS, and PWS values weighted by region size. 12 In each ROI, the product of CBF and the total oxygen content of arterial blood (Cao2) was computed as an index of oxygen transport to the cerebral tissue, and the ratio of CBF to CBV was determined as an index of cerebral perfusion pressure. The Cao2 was calculated as (1.39x Hb xSao2)+ (0.0031 xPao2), where Hb is the hemoglobin concentration, Sao2 is the arterial oxygen saturation, and Pao2 is the arterial oxygen tension. 13 The response to changes in hematocrit with hemodilution was defined as the absolute change in CBF or CBF x Cao2 with respect to the absolute change in hematocrit from before to after hemodilution.
Results obtained in the patients before and after hemodilution were compared with those obtained in six age-matched normal volunteers (four men and two women; mean+SD age, 52±18 years) using the MannWhitney U test after the Kruskal-Wallis one-way analysis of variance. We defined a statistically significant value of P<.0125 (.05/4) using Bonferroni's correction for multiple comparisons. We also compared the values obtained before and after hemodilution using the paired Wilcoxon signed-rank test. Differences of P<.05 were considered significant. The relations between the CBF and CBFxCao2 response and the PET parameters before hemodilution were analyzed using Pearson's correlation coefficient and partial correlation coefficient.
Results
The physiological parameters obtained in the patients before and after hemodilution and in the control subjects are listed in Table 2 , including the arterial hematocrit, arterial hemoglobin concentration, Paco2, Pao2, Sao2, Cao2, pH, and mean arterial blood pressure. The values obtained in the patients before and after hemodilution were not significantly different from the control values (Kruskal-Wallis one-way analysis of variance). Hemodilution significantly reduced the mean hematocrit from 41.2% to 36.3%, the hemoglobin concentration from 13.8 to 12.2 g/dL, and the Cao2 from 18.6 to 16.5 mL/dL. However, the blood gases, pH, and mean arterial blood pressure showed no significant differences after hemodilution. Table 3 shows the mean hemispheric values of CBF, CMRo2, OEF, CBV, CBF/CBV ratio, and CBFxCao2 before and after hemodilution. Before hemodilution, the patients showed significant decreases in CBF, the CBF/CBV ratio, and CBFx Cao2 as well as a significant elevation in OEF in the hemisphere with ICA occlusion compared with the control subjects. The CBF and CBF/CBV ratio were significantly decreased in the hemisphere contralateral to ICA occlusion as well. After hemodilution, only CBF, the CBF/CBV ratio, and CBFxCao2 in the hemisphere with ICA occlusion were significantly different from the control values. Fig 1 shows the mean hemispheric values of CBF, CBFxCao2, CMRo2, and OEF before and after hemodilution in each patient. Hemodilution significantly increased CBF and CBFxCao2 and significantly de- 
Discussion
We showed that ICA occlusion with a low CBF and a submaximal increase in OEF achieved an increase in both CBF and oxygen transport in the affected hemisphere with hemodilution. Subsequently, the elevated OEF decreased without a change in CMRo2, indicating that hemodilution improved the oxygen supply, which had been inadequate for tissue demands. Thus, hemodilution may have a beneficial hemodynamic effect in stroke patients with ICA occlusion showing hemodynamic compromise, although it does not change oxygen transport in the normal human brain. 5, 14 Hemodilution improved the hemodynamic state of all of the patients. However, the responses of CBF and CBFx Cao2 to a change in hematocrit were variable and correlated positively with the value of the OEF/CBV ratio before hemodilution, indicating that the effect of hemodilution was determined by the hemodynamic state before hemodilution in each patient. The OEF/ CBV ratio shows a biphasic change in the course of perfusion pressure reduction due to ICA occlusion.' In the early stage, where autoregulatory vasodilatation maintains CBF, an increase in CBV without a change in OEF causes a decrease in the OEF/CBV ratio. The minimum value is reached at the limit of autoregulation when the vessels show nearly maximal dilatation. 15 Further reductions in the perfusion pressure then produce a decrease in CBF with a compensatory increase in OEF. CBV increases further to its maximal level and thereafter may passively decrease as vessels begin to collapse. These changes lead to an increase in the However, a substantial increase in oxygen transport was also found in some hemispheres with a relatively low OEF. These hemispheres also showed a decrease in CBV with a relative high OEF/CBV ratio accompanied by almost parallel reductions in CBF and CMRo2. In stroke patients with ICA occlusion, ischemic changes or deafferentation may cause a decrease in CBV through metabolic depression, which will increase the OEF/ CBV ratio without an increase in OEF. Under these conditions, CBF may change passively in response to alterations in perfusion pressure and blood viscosity due to the loss of vascular control.16 Thus, in hemispheres showing primary metabolic depression and a high OEF/ CBV ratio, hemodilution may also increase CBF and oxygen transport.
The OEF and CBV may be two dependent factors determining the effect of hemodilution. The CBF x Cao2 response was correlated negatively with CBV, implying that the vasodilatory reserve is important. In the cat, hemodilution failed to cause an increase in CBF if blood pressure was reduced to the lower limit of autoregulation, producing maximal vasodilatation without a change in OEF.6 In addition, the CBFxCao2 response correlated positively with OEF. The degree of increase in OEF reflects the degree of reduction in CBF, which is affected by the perfusion pressure and the viscosity. It is this component of CBF reduction that hemodilution may improve through the hemorrheologic effects related to a decrease in viscosity. An experimental study in normal lamb brains has shown that the independent effect of an increase in hematocrit on CBF was related to the OEF.7'18 Although the changes in OEF and CBV are complex and mutually related under ischemic conditions, the OEF/CBV ratio may indicate the total capacity of hemodilution to increase CBF.
Although a high hematocrit is considered to be a risk factor for cerebral infarction,19 the hematocrit values in patients with ICA occlusion on antiplatelet therapy did not relate to the risk of stroke.20 This finding may have resulted from not taking account of the cerebral hemodynamics. In one study, watershed infarcts accounted for 72% of delayed strokes in patients with ICA occlusion,21 and most of the infarcts were suggested to result from hemodynamic mechanisms that included elevated hematocrit as an important factor. The difference in the cerebral hemodynamics determined at high and low hematocrit values in this study suggests that an elevation of hematocrit will worsen the hemodynamic state in patients with ICA occlusion. An increase in hematocrit may be an important risk factor for cerebral ischemia in patients who are hemodynamically compromised. In the clinical setting, the hemodynamic state of patients can be evaluated by paired CBF measurements with SPECT before and after the application of a vasodilatory stimulus. ' Risk factors, including a high hematocrit, should be managed with reference to the underlying hemodynamic state of each patient. Antiplatelet therapy is unlikely to prevent hemodynamic stroke. We must seek other specific medical therapies for patients with carotid occlusive disease who exhibit hemodynamic compromise in the form of low perfusion with increased OEF. Modifying the hematocrit may be a useful management strategy for patients with ICA occlusion showing hemodynamic ischemia.
